CB Insights
Technology Market Intelligence
Technology Market Intelligence
SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, was built for treatment of chronic motor impairments resulting from stroke.
Company (Alive / Active)
Phone:
St. Luke Tower 28F
8-1 Akashi-cho, Chuo-ku
Tokyo, 104-0044
Japan
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Extracellular matrix from pluripotent cells | Dec 03, 2008 | Jul 07, 2020 | Patent |
| Extracellular matrix from pluripotent cells | Jan 12, 2018 | May 19, 2020 | Patent |
| Methods and compositions for modulation of migration of neurogenic cells | Feb 26, 2019 | Apr 21, 2020 | Patent |
| Methods and compositions for modulating peripheral immune function | Apr 21, 2017 | Jan 28, 2020 | Patent |
| Extracellular matrix from pluripotent cells | Apr 04, 2018 | Nov 12, 2019 | Patent |
